Secondary Pneumococcal Disease in Veterans With Viral Respiratory Infections
Clinical Infectious Diseases · 09.02.2026 · 82 (1) · e185-e190
DOI: 10.1093/cid/ciaf285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 31.05.2025. Verfasst von Lauren A Powers und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Veterans, COVID-19, Respiratory Tract Infections, Influenza, Human. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Post-viral secondary bacterial infections, such as those caused by Streptococcus pneumoniae, are strongly associated with influenza and respiratory syncytial virus (RSV). However, data evaluating this relationship with coronavirus disease 2019 (COVID-19) are limited.
Methods
A retrospective analysis was conducted in hospitalized patients in Veterans Affairs (VA) hospitals across the United States from 1 January 2015 to 1 March 2025 to determine the risk of secondary S pneumoniae infection after respiratory viral disease. The primary outcome was development of S pneumoniae infection within 30 days after a positive test for influenza, RSV, or COVID-19.
Results
In total, 188 721 hospitalized patients who received care at a VA hospital were tested for a viral respiratory infection. Of those, 8165 were positive for S pneumoniae after respiratory viral testing. Both influenza and RSV infections were associated with increased odds of S pneumoniae infection (odds ratio [OR]: 2.39 [95% CI: 2.15–2.64] and 2.50 [95% CI: 2.07–2.99], respectively). However, prior COVID-19 infection decreased the odds of S pneumoniae infection (OR: .56; 95% CI: .50–.62). Additionally, current smokers and those with chronic obstructive pulmonary disease were also associated with increased odds of subsequent S pneumoniae (OR: 1.09 [95% CI: 1.03–1.16] and 1.36 [95% CI: 1.28–1.45], respectively).
Conclusions
Study results demonstrated that influenza and RSV are associated with a higher risk of post-viral secondary S pneumoniae infection, while COVID-19 did not appear to increase such risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA.
- Department of Pharmacy Practice, D'Youville School of Pharmacy, Buffalo, New York, USA.
- Department of Medicine, Division of Infectious Disease, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA.
- Department of Medicine, Division of Infectious Disease, University at Buffalo, Buffalo, New York, USA.
ORCID-Profile: Matthew Davis, Ashley L O'Leary, John C Hu
Zitieren
APA
Powers, L. A., Chan, A. K., Wattengel, B. A., Davis, M., O'Leary, A. L., Xu, J., Hu, J. C., & Mergenhagen, K. A. (2026). Secondary Pneumococcal Disease in Veterans With Viral Respiratory Infections. Clinical Infectious Diseases, 82(1), e185-e190. https://doi.org/10.1093/cid/ciaf285
Vancouver
Powers LA, Chan AK, Wattengel BA, Davis M, O'Leary AL, Xu J, et al. Secondary Pneumococcal Disease in Veterans With Viral Respiratory Infections. Clinical Infectious Diseases. 2026;82(1):e185-e190. doi:10.1093/cid/ciaf285
BibTeX
@article{Powers2026,
author = {Powers, Lauren A and Chan, Arthur K and Wattengel, Bethany A and Davis, Matthew and O'Leary, Ashley L and Xu, Jiachen and Hu, John C and Mergenhagen, Kari A},
title = {Secondary Pneumococcal Disease in Veterans With Viral Respiratory Infections},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {82},
number = {1},
pages = {e185--e190},
doi = {10.1093/cid/ciaf285}
}
EUVIMED